These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8088760)

  • 1. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay.
    Roger P; Montcourrier P; Maudelonde T; Brouillet JP; Pages A; Laffargue F; Rochefort H
    Hum Pathol; 1994 Sep; 25(9):863-71. PubMed ID: 8088760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay.
    Maudelonde T; Brouillet JP; Roger P; Giraudier V; Pages A; Rochefort H
    Eur J Cancer; 1992; 28A(10):1686-91. PubMed ID: 1389486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.
    Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H
    Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
    Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
    Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
    Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
    Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.
    Veneroni S; Daidone MG; Di Fronzo G; Cappelletti V; Amadori D; Riccobon A; Paradiso A; Correale M; Silvestrini R
    Breast Cancer Res Treat; 1993; 26(1):7-13. PubMed ID: 8400325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.
    Hantschmann P; Beysiegel S; Kurzl R
    J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
    Göhring UJ; Ingenhorst A; Crombach G; Scharl A
    Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer.
    Nadji M; Fresno M; Nassiri M; Conner G; Herrero A; Morales AR
    Hum Pathol; 1996 Sep; 27(9):890-5. PubMed ID: 8816882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia.
    Paradiso A; Mangia A; Correale M; Abbate I; Ferri G; Piffanelli A; Catozzi L; Amadori D; Riccobon A; De Lena M
    Breast Cancer Res Treat; 1992; 23(1-2):63-70. PubMed ID: 1446053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical significance of cathepsin D in breast cancer metastasis.
    Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
    Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors.
    Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
    J Pathol; 1993 Aug; 170(4):463-70. PubMed ID: 8410496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
    Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
    J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.
    Capony F; Rougeot C; Montcourrier P; Cavailles V; Salazar G; Rochefort H
    Cancer Res; 1989 Jul; 49(14):3904-9. PubMed ID: 2736531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx.
    Marsigliante S; Biscozzo L; Resta L; Leo G; Mottaghi A; Maiorano E; Colucci G; Storelli C
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):51-5. PubMed ID: 9135974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.
    Capony F; Braulke T; Rougeot C; Roux S; Montcourrier P; Rochefort H
    Exp Cell Res; 1994 Nov; 215(1):154-63. PubMed ID: 7957663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay.
    Brouillet JP; Dufour F; Lemamy G; Garcia M; Schlup N; Grenier J; Mani JC; Rochefort H
    Cancer; 1997 Jun; 79(11):2132-6. PubMed ID: 9179059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
    Escot C; Zhao Y; Puech C; Rochefort H
    Breast Cancer Res Treat; 1996; 38(2):217-26. PubMed ID: 8861840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of two methods for determination of cathepsin D in breast carcinoma (immunohistochemistry and ELISA in cytosol).
    Razumović JJ; Stojković RR; Petrovecki M; Gamulin S
    Breast Cancer Res Treat; 1997 Apr; 43(2):117-22. PubMed ID: 9131266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.